University Multiprofile Hospital for Active Treatment Alexandrovska

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Alzheimer disease1 trial
• Follicular lymphoma1 trial

Phase

• Phase 22 trials
• Phase 31 trial

Status

• Completed2 trials
• Not yet recruiting1 trial

Lead sponsor

• BeiGene1 trial
• Otsuka Pharmaceutical Development & Commercialization, Inc.1 trial
• Ribocure Pharmaceuticals AB1 trial

Running trials

• Not yet recruiting

  Vortosiran for VTE Prevention

  NCT07850453· Phase 2· Ribocure Pharmaceuticals AB· Source

  Contact: Kirik Karamfiloff, Professor

Closed trials

• Completed

  A Study Comparing Obinutuzumab and BGB-3111 Versus Obinutuzumab Alone in Treating R/R Follicular Lymphoma

  NCT03332017· Phase 2· BeiGene· Source

• Completed

  Assessment of the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

  NCT03393520· Phase 3· Otsuka Pharmaceutical Development & Commercialization, Inc.· Source